RT Journal Article
SR Electronic
T1 Biallelic variants in <em>HMGCS1</em> are a novel cause of rare rigid spine syndrome
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.10.25.23297129
DO 10.1101/2023.10.25.23297129
A1 Dofash, Lein NH
A1 Miles, Lee B
A1 Saito, Yoshihiko
A1 Rivas, Eloy
A1 Calcinotto, Vanessa
A1 Oveissi, Sara
A1 Serrano, Rita J
A1 Templin, Rachel
A1 Ramm, Georg
A1 Rodger, Alison
A1 Haywood, Joel
A1 Ingley, Evan
A1 Clayton, Joshua S
A1 Taylor, Rhonda L
A1 Folland, Chiara L
A1 Groth, David
A1 Hock, Daniella H
A1 Stroud, David A
A1 Gorokhova, Svetlana
A1 Donkervoort, Sandra
A1 Bönnemann, Carsten G
A1 Sud, Malika
A1 VanNoy, Grace
A1 Mangilog, Brian E
A1 Pais, Lynn
A1 Madruga-Garrido, Marcos
A1 Scala, Marcello
A1 Fiorillo, Chiara
A1 Baratto, Serena
A1 Traverso, Monica
A1 Bruno, Claudio
A1 Zara, Federico
A1 Paradas, Carmen
A1 Ogata, Katsuhisa
A1 Nishino, Ichizo
A1 Laing, Nigel G
A1 Bryson-Richardson, Robert J
A1 Cabrera-Serrano, Macarena
A1 Ravenscroft, Gianina
YR 2023
UL http://medrxiv.org/content/early/2023/10/28/2023.10.25.23297129.abstract
AB Rigid spine syndrome is a rare childhood-onset myopathy characterised by slowly progressive or non-progressive scoliosis, neck and spine contractures, hypotonia, and respiratory insufficiency. Biallelic variants in SELENON account for most cases of rigid spine syndrome, however, the underlying genetic cause in some patients remains unexplained.In this study, we used exome and genome sequencing to investigate the genetic basis of rigid spine syndrome in patients without a genetic diagnosis. In five patients from four unrelated families, we identified biallelic variants in HMGCS1 (3-hydroxy-3-methylglutaryl-coenzyme A synthase). These included six missense variants and one frameshift variant distributed throughout HMGCS1. All patients presented with spinal rigidity primarily affecting the cervical and dorsolumbar regions, scoliosis, and respiratory insufficiency. Creatine kinase levels were variably elevated. The clinical course worsened with intercurrent disease or certain drugs in some patients; one patient died from respiratory failure following infection. Muscle biopsies revealed irregularities in oxidative enzyme staining with occasional internal nuclei and rimmed vacuoles.HMGCS1 encodes a key enzyme of the mevalonate pathway, disturbance of which is also associated with HMGCR-limb girdle muscular dystrophy and GGPS1-muscular dystrophy. Quantitative PCR and western blotting confirmed HMGCS1 abundance in skeletal muscle and myogenic precursors. HMGCS1 levels in skeletal muscle were comparable between healthy controls and the index case with a homozygous p.(S447P) substitution. Muscle RNA-seq for a patient with a frameshift variant (c.344_345del:p.S115Wfs*12) and an in trans substitution (p.(Q29L)) showed HMGCS1 transcript levels reduced to 53% compared to controls. The substitution appeared homozygous on RNA-seq, suggesting the allele harbouring the frameshift variant undergoes nonsense mediated decay.hmgcs1-/- zebrafish displayed severe early defects, including immobility at 2 days and death by days 3 post-fertilisation. We anticipate that the variants observed in this cohort have subtle effects on HMGCS1 function given most patients survived to adulthood. In support of the variants being hypomorphic, analyses of recombinant human HMGCS1 protein and four mutants (p.S447P, p.Q29L, p.M70T, p.C268S) showed all mutants maintained their secondary structure and dimerized state and had enzymatic activity comparable to the wildtype. Thermal stability of the mutants was similar or slightly reduced compared to the wildtype. Altogether, our analyses suggest that the identified missense variants in HMGCS1 act through a hypomorphic mechanism yet to be elucidated.Here, we report an additional component of the mevalonate pathway associated with myopathy and suggest biallelic variants in HMGCS1 should be considered in patients presenting with an unresolved rigid spine phenotype.Competing Interest StatementThe authors have declared no competing interest.Funding StatementLNHD is supported by an Australian Government Research Training Program (RTP) Scholarship. GR (Investigator Grant, APP2007769), NGL (Fellowship APP1117510) and DS (Investigator Grant, APP2009732) are supported by the Australian NHMRC. This work is also supported by an NHMRC Ideas Grant (APP2002640). Sequencing and analysis of JPN1 were supported partly by Intramural Research Grant (2-5 and 5-6) for Neurological and Psychiatric Disorders of NCNP, and Japan Agency for Medical Research and Development under Grant Numbers 22ek0109490h0003. Sequencing and analysis of USA1 and USA2 were provided by the Broad Institute of MIT and Harvard Center for Mendelian Genomics (Broad CMG) and were funded by the National Human Genome Research Institute grants UM1 HG008900 and R01 HG009141 (with additional support from the National Eye Institute, and the National Heart, Lung and Blood Institute), and in part by grant number 2020224274 from the Chan Zuckerberg Initiative DAF, an advised fund of Silicon Valley Community Foundation. The work in CG. Bönnemanns laboratory is supported by intramural funds from the NIH National Institute of Neurological Disorders and Stroke.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Human Research Ethics Office of the University of Western Australia gave ethical approval for this work. The Human Research Ethics Office of the National Center of Neurology and Psychiatry in Japan gave ethical approval for this work. The Ethics Committee of the Gaslini Children's Hospital gave ethical approval for this work The Institutional Review Board of the Mass General Brigham gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data and constructs generated by this study are available upon request.AcAc-CoAacetoacetyl coenzyme AAc-CoAacetyl coenzyme ACDcircular dichroismHMG-CoA3-hydroxy-3-methylglutaryl coenzyme AKmMichaelis constantMRImagnetic resonance imagingTPMtranscripts per millionVmaxmaximum velocityWESwhole exome sequencingWGSwhole genome sequencing